| Maple Valley - Anthon Oto Csd | |
|
110 W Division St Anthon IA 51004-8192 | |
| (712) 373-5246 | |
| (712) 373-5326 |
| Full Name | Maple Valley - Anthon Oto Csd |
|---|---|
| Speciality | Behavior Analyst |
| Location | 110 W Division St, Anthon, Iowa |
| Authorized Official Name and Position | Shona Klingensmith (BUSINESS MANAGER) |
| Authorized Official Contact | 7123735246 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Maple Valley - Anthon Oto Csd 110 W. Division St. Anthon IA 51004-8192 Ph: (712) 373-5246 | Maple Valley - Anthon Oto Csd 110 W Division St Anthon IA 51004-8192 Ph: (712) 373-5246 |
| NPI Number | 1942649579 |
|---|---|
| Provider Enumeration Date | 06/17/2013 |
| Last Update Date | 06/17/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942649579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
News Archive
Merz Pharmaceuticals announced today that data from stability and clinical studies evaluating Xeomin (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, will be presented at the 71st Annual Assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) in Seattle, Wash.
Volcano Corporation, a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it received clearance to market the Eagle Eye Platinum digital IVUS catheter in Japan, and will introduce the device at the 20th PCI Live Demonstration Course in Kurashiki, which starts on March 3rd.
Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
A century-old posture improvement technique developed by Shakespearian actor F.M. Alexander to correct his chronic laryngitis appears to enhance the posture and proficiency of surgeons who perform minimally invasive procedures.
› Verified 2 days ago